HMGB1 induces lung fibroblast to myofibroblast differentiation through NF‑κB‑mediated TGF‑β1 release

Wang,Qiong; Wang,Jun; Wang,Junfang; Hong,Shanchao; Han,Feifei; Chen,Jingyu; Chen,Guoqian

doi:10.3892/mmr.2017.6364

HMGB1 induces lung fibroblast to myofibroblast differentiation through NF‑κB‑mediated TGF‑β1 release

Authors:
- Qiong Wang
- Jun Wang
- Junfang Wang
- Shanchao Hong
- Feifei Han
- Jingyu Chen
- Guoqian Chen
View Affiliations

Affiliations: Department of Clinical Laboratory, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, P.R. China, Department of Respiration, Suzhou Kowloon Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Suzhou, Jiangsu 215000, P.R. China, Department of Orthopedics, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, P.R. China, Department of Thoracic Surgery, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, P.R. China
Published online on: March 23, 2017 https://doi.org/10.3892/mmr.2017.6364
Pages: 3062-3068
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The proinflammatory factor high‑mobility group box protein 1 (HMGB1) has been implicated in the pathogenesis of lung fibrosis; however, the role of HMGB1 in lung fibrosis remains unclear. It has previously been reported that nuclear factor (NF)‑κB and transforming growth factor (TGF)‑β1 may be involved in lung fibrosis. Therefore, the present study aimed to examine the potential molecular mechanisms that underlie HMGB1‑induced lung fibrosis via the regulation of NF‑κB and TGF‑β1. The results demonstrated that HMGB1 stimulation increased the activation of NF‑κB and the release of TGF‑β1, as well as the expression of α‑smooth muscle actin (α‑SMA) and collagen I in human lung fibroblasts in vitro. In addition, inhibition of NF‑κB activation blocked HMGB1‑induced TGF‑β1 release, as well as α‑SMA and collagen I expression in lung fibroblasts. Preventing the release of TGF‑β1 inhibited HMGB1‑induced α‑SMA and collagen I expression; however, it had no effect on NF‑κB activation. Collectively, these findings indicate that HMGB1 induces fibroblast to myofibroblast differentiation of lung fibroblasts via NF‑κB‑mediated TGF‑β1 release.

View Figures

View References

1	Górka J, Szczeklik W, Włudarczyk A, Łoboda P, Chmura Ł and Musiał J: Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti-MDA5 antibodies. Pol Arch Med Wewn. 125:685–686. 2015.PubMed/NCBI
2	MacKenzie B, Korfei M, Henneke I, Sibinska Z, Tian X, Hezel S, Dilai S, Wasnick R, Schneider B, Wilhelm J, et al: Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis. Respir Res. 16:832015. View Article : Google Scholar : PubMed/NCBI
3	Curtis JR, Sarsour K, Napalkov P, Costa LA and Schulman KL: Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study. Arthritis Res Ther. 17:3192015. View Article : Google Scholar : PubMed/NCBI
4	Yamamoto Y, Okamoto I, Otsubo K, Iwama E, Hamada N, Harada T, Takayama K and Nakanishi Y: Severe acute interstitial lung disease in a patient with anaplastic lymphoma kinase rearrangement-positive non-small cell lung cancer treated with alectinib. Invest New Drugs. 33:1148–1150. 2015. View Article : Google Scholar : PubMed/NCBI
5	Guo Y, Zhang X, Qin M and Wang X: Changes in peripheral CD19(+)Foxp3(+) andCD19(+)TGFβ(+) regulatory B cell populations in rheumatoid arthritis patients with interstitial lung disease. J Thorac Dis. 7:471–477. 2015.PubMed/NCBI
6	Kawai T, Watanabe N, Yokoyama M, Nakazawa Y, Goto F, Uchiyama T, Higuchi M, Maekawa T, Tamura E, Nagasaka S, et al: Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease. J Clin Immunol. 34:933–940. 2014. View Article : Google Scholar : PubMed/NCBI
7	Glasser SW, Senft AP, Maxfield MD, Ruetschilling TL, Baatz JE, Page K and Korfhagen TR: Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury. Respir Res. 14:192013. View Article : Google Scholar : PubMed/NCBI
8	Lin L, Wang Y, Liu W and Huang Y: BAMBI inhibits skin fibrosis in keloid through suppressing TGF-β1-induced hypernomic fibroblast cell proliferation and excessive accumulation of collagen I. Int J Clin Exp Med. 8:13227–13234. 2015.PubMed/NCBI
9	Tsukui T, Ueha S, Shichino S, Inagaki Y and Matsushima K: Intratracheal cell transfer demonstrates the profibrotic potential of resident fibroblasts in pulmonary fibrosis. Am J Pathol. 185:2939–2948. 2015. View Article : Google Scholar : PubMed/NCBI
10	Geng J, Huang X, Li Y, Xu X, Li S, Jiang D, Liang J, Jiang D, Wang C and Dai H: Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis. Respir Res. 16:1242015. View Article : Google Scholar : PubMed/NCBI
11	Ma X, Yang F, Yang S, Rasul A, Li T, Liu L, Kong M, Guo D and Ma T: Number and distribution of myofibroblasts and α-smooth muscle actin expression levels in fetal membranes with and without gestational complications. Mol Med Rep. 12:2784–2792. 2015.PubMed/NCBI
12	Jung YS, Liu XW, Chirco R, Warner RB, Fridman R and Kim HR: TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain. PLoS One. 7:e387732012. View Article : Google Scholar : PubMed/NCBI
13	Watson M, Stott K, Fischl H, Cato L and Thomas JO: Characterization of the interaction between HMGB1 and H3-a possible means of positioning HMGB1 in chromatin. Nucleic Acids Res. 42:848–859. 2014. View Article : Google Scholar : PubMed/NCBI
14	Little AJ, Corbett E, Ortega F and Schatz DG: Cooperative recruitment of HMGB1 during V (D)J recombination through interactions with RAG1 and DNA. Nucleic Acids Res. 41:3289–3301. 2013. View Article : Google Scholar : PubMed/NCBI
15	Zhao T, Ren H, Wang X, Liu P, Yan F, Jiang W, Li Y, Li J, Gribben JG, Jia L and Hao J: Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma. Oncotarget. 6:27816–27831. 2015. View Article : Google Scholar : PubMed/NCBI
16	Jiang G, Wang Y, Yun J, Hajrasouliha AR, Zhao Y, Sun D, Kaplan HJ and Shao H: HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent. J Neuroinflammation. 12:1792015. View Article : Google Scholar : PubMed/NCBI
17	Tabata C, Kanemura S, Tabata R, Masachika E, Shibata E, Otsuki T, Nishizaki T and Nakano T: Serum HMGB1 as a diagnostic marker for malignant peritoneal mesothelioma. J Clin Gastroenterol. 47:684–688. 2013. View Article : Google Scholar : PubMed/NCBI
18	Laws TR, Clark GC and D'Elia RV: Immune profiling of the progression of a BALB/c mouse aerosol infection by Burkholderia pseudomallei and the therapeutic implications of targeting HMGB1. Int J Infect Dis. 40:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
19	Qi L, Sun X, Li FE, Zhu BS, Braun FK, Liu ZQ, Tang JL, Wu C, Xu F, Wang HH, et al: HMGB1 promotes mitochondrial dysfunction-triggered striatal neurodegeneration via autophagy and apoptosis activation. PLoS One. 10:e01429012015. View Article : Google Scholar : PubMed/NCBI
20	Parodi M, Pedrazzi M, Cantoni C, Averna M, Patrone M, Cavaletto M, Spertino S, Pende D, Balsamo M, Pietra G, et al: Natural killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic high mobility group box-1 (HMGB1) capable of amplifying NK cell recruitment. Oncoimmunology. 4:e10523532015. View Article : Google Scholar : PubMed/NCBI
21	Wang FP, Li L, Li J, Wang JY, Wang LY and Jiang W: High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK. PLoS One. 8:e643732013. View Article : Google Scholar : PubMed/NCBI
22	Zhang W, Lavine KJ, Epelman S, Evans SA, Weinheimer CJ, Barger PM and Mann DL: Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J Am Heart Assoc. 4:e0019932015. View Article : Google Scholar : PubMed/NCBI
23	Zhang M, Guo Y, Fu H, Hu S, Pan J, Wang Y, Cheng J, Song J, Yu Q, Zhang S, et al: Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling. Cell Death Dis. 6:e18472015. View Article : Google Scholar : PubMed/NCBI
24	Ebina M, Taniguchi H, Miyasho T, Yamada S, Shibata N, Ohta H, Hisata S, Ohkouchi S, Tamada T, Nishimura H, et al: Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis. Pulm Med. 2011:9164862011. View Article : Google Scholar : PubMed/NCBI
25	Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, Yamada S, Kuwano K and Nakanishi Y: The role of high mobility group box 1 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 39:440–447. 2008. View Article : Google Scholar : PubMed/NCBI
26	Tiringer K, Treis A, Kanolzer S, Witt C, Ghanim B, Gruber S, Schmidthaler K, Renner S, Dehlink E, Nachbaur E, et al: Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients. Eur Respir J. 44:802–805. 2014. View Article : Google Scholar : PubMed/NCBI
27	Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD, et al: Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas aeruginosa pneumonia in cystic fibrosis. Mol Med. 18:477–485. 2012. View Article : Google Scholar : PubMed/NCBI
28	Li LC, Li DL, Xu L, Mo XT, Cui WH, Zhao P, Zhou WC, Gao J and Li J: High-mobility group box 1 mediates epithelial-to-mesenchymal transition in pulmonary fibrosis involving transforming growth factor-β1/Smad2/3 signaling. J Pharmacol Exp Ther. 354:302–309. 2015. View Article : Google Scholar : PubMed/NCBI
29	Yang Z, Sun Z, Liu H, Ren Y, Shao D, Zhang W, Lin J, Wolfram J, Wang F and Nie S: Connective tissue growth factor stimulates the proliferation, migration and differentiation of lung fibroblasts during paraquat-induced pulmonary fibrosis. Mol Med Rep. 12:1091–1097. 2015.PubMed/NCBI
30	Hou F, Wang L, Wang H, Gu J, Li M, Zhang J, Ling X, Gao X and Luo C: Elevated gene expression of S100A12 is correlated with the predominant clinical inflammatory factors in patients with bacterial pneumonia. Mol Med Rep. 11:4345–4352. 2015.PubMed/NCBI
31	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
32	Di JM, Pang J, Pu XY, Zhang Y, Liu XP, Fang YQ, Ruan XX and Gao X: Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer Genet Cytogenet. 192:60–67. 2009. View Article : Google Scholar : PubMed/NCBI
33	Petrosyan F, Culver DA and Reddy AJ: Role of bronchoalveolar lavage in the diagnosis of acute exacerbations of idiopathic pulmonary fibrosis: A retrospective study. BMC Pulm Med. 15:702015. View Article : Google Scholar : PubMed/NCBI
34	Ji H, Tang H, Lin H, Mao J, Gao L, Liu J and Wu T: Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation. Biomed Rep. 2:787–792. 2014.PubMed/NCBI
35	Sassoli C, Chellini F, Pini A, Tani A, Nistri S, Nosi D, Zecchi-Orlandini S, Bani D and Formigli L: Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. PLoS One. 8:e638962013. View Article : Google Scholar : PubMed/NCBI
36	Song J, Zhu Y, Li J, Liu J, Gao Y, Ha T, Que L, Liu L, Zhu G, Chen Q, et al: Pellino1-mediated TGF-β1 synthesis contributes to mechanical stress induced cardiac fibroblast activation. J Mol Cell Cardiol. 79:145–156. 2015. View Article : Google Scholar : PubMed/NCBI
37	Bizzarro V, Fontanella B, Carratù A, Belvedere R, Marfella R, Parente L and Petrella A: Annexin A1 N-terminal derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions. PLoS One. 7:e456392012. View Article : Google Scholar : PubMed/NCBI
38	Li W, Xu Q, Deng Y, Yang Z, Xing S, Zhao X, Zhu P, Wang X, He Z and Gao Y: High-mobility group box 1 accelerates lipopolysaccharide-induced lung fibroblast proliferation in vitro: involvement of the NF-κB signaling pathway. Lab Invest. 95:635–647. 2015. View Article : Google Scholar : PubMed/NCBI
39	Pedroza M, Le TT, Lewis K, Karmouty-Quintana H, To S, George AT, Blackburn MR, Tweardy DJ and Agarwal SK: STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation. FASEB J. 30:129–140. 2016. View Article : Google Scholar : PubMed/NCBI